Tempus IPS
Multi-omic algorithmic laboratory-developed test that generates an Immune Profile Score in metastatic or stage IV solid tumors.
- Developer
- Tempus AI
- Intended use
- Risk Stratification
- Cancer scope
- Solid tumors
- Specimen
- FFPE tumor tissue
- Molecular modality
- Multi-omics
- Current version
- Current clinical Tempus Immune Profile Score algorithmic LDT (2026-09)
- Evidence context
- 0 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.